On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Sarepta Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Sarepta Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Sarepta Therapeutics (United States)?

ScholarIQrecord summary

Sarepta Therapeutics (United States) is a research organisation in Cambridge, US. OpenAlex records 964 works and 90,373 citations for it. 557 researchers list it as their most recent affiliation.

How many works does Sarepta Therapeutics (United States) have?

ScholarIQindexed works

Sarepta Therapeutics (United States) has 964 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Sarepta Therapeutics (United States) →

How many citations does Sarepta Therapeutics (United States) have?

ScholarIQcitation count

Sarepta Therapeutics (United States) has 90,373 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Sarepta Therapeutics (United States) →

How many researchers are at Sarepta Therapeutics (United States)?

ScholarIQresearcher count

Sarepta Therapeutics (United States) has 557 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Sarepta Therapeutics (United States)?

ScholarIQavg h-index

Sarepta Therapeutics (United States) has an average h-index of 68 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Sarepta Therapeutics (United States)?

ScholarIQror

The ROR for Sarepta Therapeutics (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Sarepta Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Sarepta Therapeutics (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Sarepta Therapeutics (United States)?

ScholarIQtop researchers by citations

Somasekar Seshagiri · Ferroptosis and cancer prognosis

252 works26,760 citations

What are the most-cited papers on Sarepta Therapeutics (United States)?

ScholarIQmost cited works

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

Charles M. Rudin, Steffen Durinck, Eric Stawiski, John T. Poirier, Zora Modrušan, David S. Shames, Emily Anne Smith Bergbower, Yinghui Guan, James Shin, Joseph Guillory, Celina Sanchez Rivers, Catherine K. Foo, Deepali Bhatt, Jeremy Stinson, Florian Gnad, Peter M. Haverty, Robert Gentleman, Subhra Chaudhuri, Vasantharajan Janakiraman, Bijay S. Jaiswal, Chaitali Parikh, Wenlin Yuan, Zemin Zhang, Hartmut Koeppen, Thomas D. Wu, Howard M. Stern, Robert L. Yauch, Kenneth E. Huffman, Diego D’Ávila Paskulin, Peter B. Illei, Marileila Varella‐Garcia, Adi F. Gazdar, Frédéric J. de Sauvage, Richard Bourgon, John D. Minna, Malcolm V. Brock, Somasekar Seshagiri

Nature Genetics. 20121,105 Citations

Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin

Albert Lai, Samir Kharbanda, Whitney B. Pope, Anh Tran, Orestes E. Solis, Franklin Peale, William F. Forrest, Kanan Pujara, Jose Carrillo, Ajay Pandita, Benjamin M. Ellingson, Chauncey W. Bowers, Robert Soriano, Nils Ole Schmidt, Sankar Mohan, William H. Yong, Somasekar Seshagiri, Zora Modrušan, Zhaoshi Jiang, Kenneth Aldape, Paul S. Mischel, Linda M. Liau, Cameron Escovedo, Weidong Chen, Phioanh L. Nghiemphu, C. David James, Michael D. Prados, Manfred Westphal, Katrin Lamszus, Timothy F. Cloughesy, Heidi Phillips

Journal of Clinical Oncology. 2011444 CitationsOPEN ACCESS

How much of the research on Sarepta Therapeutics (United States) is open access?

ScholarIQopen access share

50%OPEN ACCESS

Gold

Green

Hybrid

Bronze

50%

Closed

50%